Nurse Practitioners Secure No. 1 Spot Across Three U.S. News & World Report Best Jobs Rankings 
CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
NEWARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Clarapath, Medical Robotics Company, Raises $32M in Additional Funding
Closing 100 Year-Old Missing Link: Dramatically Improves Pathology Workflow with Intelligent Robotics and Utilizes Proprietary Inputs for Next-Gen Precision Medicine...
Simply Better Brands Corp. Announces USD$2.6 Million Monthly Revenue For October 2021 Driven by Accelerated Customer Acquisition
VANCOUVER, British Columbia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. ("SBBC" or the "Company") (TSX Venture: SBBC)...
Artizan Biosciences and Biohaven Therapeutics Announce Therapeutic Development Program in Parkinson’s Disease
Biohaven to leverage Artizan’s biobanking expertise and proprietary drug discovery engine to create Parkinson’s disease drug development programNEW HAVEN, Conn.,...
Abeona Therapeutics Announces Support of EB Research Partnership’s Venture Into Cures Event to Raise Awareness for Education and Research of Epidermolysis Bullosa
NEW YORK and CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene...
EMA Provides Regulatory Path for Pediatric Label Extension for NexoBrid
Anticipate Submission for Label Extension in First Half 2022YAVNE, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD)...
Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
Company expects to initiate Phase 2 trial in basal cell carcinoma in 1Q 2022 Non-melanoma skin cancers are the most...
BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing
-Innovative financing facility and existing cash balance gives BridgeBio access to over $1.2 billion, which is expected to fully fund...
Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors
MENLO PARK, Calif. and BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering...
Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism
NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market
IRVINE, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal...
Orchard Therapeutics Announces New England Journal of Medicine Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome
100 percent overall survival with median follow-up of two years post-treatment with HSC gene therapy Preliminary findings show promising metabolic...
CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market
LUND, Sweden, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal...
Matinas BioPharma to Participate in 33rd Annual Piper Sandler Virtual Healthcare Conference
BEDMINSTER, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on...
Medicenna Receives Award for Excellence in Clinical Trials in Connection with an Upcoming Presentation at the 26th Annual Meeting of the Society for Neuro-Oncology
TORONTO and HOUSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA),...
The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease
Peer Reviewed Results from PROPEL Show Treatment with AT-GAA Provided Clinically Meaningful Improvements Over Standard of Care, including ERT Experienced...
NervGen Pharma Reports Third Quarter 2021 Results
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
PreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest’s Sol-Gel Technology for Delivery of Cannabinoids
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...
Northeastern Center Selects Streamline’s SmartCare As Their Next Electronic Health Record (EHR)
OAKBROOK TERRACE, Ill.--(BUSINESS WIRE)--Following a comprehensive evaluation, Northeastern Center, headquartered in Kendallville, Indiana, has selected Streamline Healthcare Solutions (Streamline) as...
Outset Medical Named to Fast Company’s First-Ever List of the Next Big Things in Tech
New Recognition Program Highlights Tech Breakthroughs That Promise to Define the Future of Their Industries SAN JOSE, Calif.--(BUSINESS WIRE)--#BetterBeginsNow--Outset Medical,...